HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise against HPV-Driven cancers
Disease control OngoingThis study tests a combination of two drugs, TG4001 and avelumab, in people with advanced cancers caused by HPV-16. The goal is to see if the combination can shrink tumors or slow disease progression better than avelumab alone. About 143 adults with cervical, anal, penile, or vul…
Matched conditions: HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Custom immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a personalized cell therapy called T-Plex for people with advanced solid tumors that have not responded to standard treatments. The therapy uses a patient's own immune cells, engineered to recognize and attack cancer cells. The main goal is to check s…
Matched conditions: HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:33 UTC